AgeX Therapeutics, Inc. (AGE)

SG&A Expense Growth

14.27%

Fiscal year · Period ending:

AGE logo

AGE SG&A Expense Growth

Latest reported14.27%
AGE FY SG&A Growth (YoY) (0.00% → 14.27%)
High-resolution chart · PNG

AGE sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
14.2664%
3.1732%
56.2217%
-10.9869%
-9.3881%
-9.0429%
44.1296%
45.955%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.